Chemotherapy

"Fundamentally, there's something broken in how the market works"

Increased risk for non-melanoma skin cancer, MDS, AML versus the general population

"How are we here in 2023 having some of these discussions?" bemoans gynecologic cancer expert

A year of DOAC therapy did not result in significantly more bleeds in ONCO DVT trial

Experts will discuss the chemotherapy drug shortages and the impact on patients

News, features, and commentary about cancer-related issues

But PFS, OS longer with ICIs plus chemotherapy among patients treated with PPIs

Higher short-term dysphagia risk with surgery, but RT/CRT had worse 5-year OS

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues

"Practice changing" findings for tough-to-treat patient population

Impressive 3-year invasive DFS seen with adaptive response strategy using FDG-PET

News, features, and commentary about cancer-related issues

5-year PFS rate represented "significant improvement" over historical 2-year rate, authors say